Development of magnesium chelate (‘magnesia’) by Master Pharm S.A. (Q101105): Difference between revisions
Jump to navigation
Jump to search
(Changed an Item) |
(Created claim: summary (P836): The project involves the R & D work leading to the development of magnesium chelate of technologies. A new active substance — chelated magnesium is used in a supplement to the next generation of diets. This supplement will permit the supply of magnesium in the form of a chelating agent in the form of chelate of magnesium ion time parameters and bioavailability, and consequently an optimised impact on maintaining the appropriate level of magnesiu...) |
||
| Property / summary | |||
The project involves the R & D work leading to the development of magnesium chelate of technologies. A new active substance — chelated magnesium is used in a supplement to the next generation of diets. This supplement will permit the supply of magnesium in the form of a chelating agent in the form of chelate of magnesium ion time parameters and bioavailability, and consequently an optimised impact on maintaining the appropriate level of magnesium in the body. (a) industrial research on: The choice of a central metal precursor, the selection of the chemist, the choice of the synthetic pathway, — verification of the synthetic path on a laboratory scale, (b) experimental development of: — verification of a synthetic pathway of the technical and semi-technical scale, — the development of the final form of the technology together with the tests in real conditions. The project will allow the development of an innovative product in the world, a supplement to the new generation of diets based on the use of new magnesium chelate of products. R & D will allow the development of innovative solutions to enable them to be placed into market, as they include tests and validation in the context of the first production. Product indicators: Number of enterprises supported (C001): 1 Number of enterprises receiving subsidies (CO02): 1 Private investment complementary to public support for enterprises (grants) (CO06): PLN 357257,70 Number of enterprises supported for R & D activities: 1 Number of R & D ongoing: 1 Number of R & D projects carried out: 1 Direct result indicator: Number of R & D results generated by the company in the project: 1 A food supplement developed within the framework of the project will be directed to the markets of: Poland and foreign, both retail (sales under their own mark (English) | |||
| Property / summary: The project involves the R & D work leading to the development of magnesium chelate of technologies. A new active substance — chelated magnesium is used in a supplement to the next generation of diets. This supplement will permit the supply of magnesium in the form of a chelating agent in the form of chelate of magnesium ion time parameters and bioavailability, and consequently an optimised impact on maintaining the appropriate level of magnesium in the body. (a) industrial research on: The choice of a central metal precursor, the selection of the chemist, the choice of the synthetic pathway, — verification of the synthetic path on a laboratory scale, (b) experimental development of: — verification of a synthetic pathway of the technical and semi-technical scale, — the development of the final form of the technology together with the tests in real conditions. The project will allow the development of an innovative product in the world, a supplement to the new generation of diets based on the use of new magnesium chelate of products. R & D will allow the development of innovative solutions to enable them to be placed into market, as they include tests and validation in the context of the first production. Product indicators: Number of enterprises supported (C001): 1 Number of enterprises receiving subsidies (CO02): 1 Private investment complementary to public support for enterprises (grants) (CO06): PLN 357257,70 Number of enterprises supported for R & D activities: 1 Number of R & D ongoing: 1 Number of R & D projects carried out: 1 Direct result indicator: Number of R & D results generated by the company in the project: 1 A food supplement developed within the framework of the project will be directed to the markets of: Poland and foreign, both retail (sales under their own mark (English) / rank | |||
Normal rank | |||
Revision as of 09:25, 6 March 2020
Project in Poland financed by DG Regio
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Development of magnesium chelate (‘magnesia’) by Master Pharm S.A. |
Project in Poland financed by DG Regio |
Statements
561,577.5 zloty
0 references
918,835.2 zloty
0 references
63.02 percent
0 references
1 October 2018
0 references
31 March 2020
0 references
MASTER PHARM SPÓŁKA AKCYJNA
0 references
51°46'23.2"N, 19°28'42.2"E
0 references
Przedmiotem projektu są prace B+R prowadzące do opracowania technologii chelatowania magnezu. Opracowana nowa substancja aktywna - chelatowany magnez - zostanie zastosowana w suplemencie diety nowej generacji. Suplement ten pozwoli na dostarczanie magnezu w formie chelatu charakteryzującego się zbalansowanymi parametrami czasu uwalniania jonów magnezu oraz biodostępności, i w konsekwencji zoptymalizowanym wpływem w zakresie utrzymywania właściwego poziomu magnezu w organizmie Prace B+R prowadzące do opracowania technologii chelatowania magnezu będą obejmowały przeprowadzenie: a) badań przemysłowych w zakresie: - wyboru prekursora metalu centralnego, - wyboru chelatora, - wyboru ścieżki syntetycznej, - weryfikacji ścieżki syntetycznej w skali laboratoryjnej. b) eksperymentalnych prac rozwojowych w zakresie: - weryfikacji ścieżki syntetycznej w skali ćwierćtechnicznej i półtechnicznej, - opracowania ostatecznej postaci technologii wraz z testami w warunkach rzeczywistych. Projekt pozwoli na opracowanie innowacyjnego w skali świata produktu - suplementu diety nowej generacji opartego na wykorzystaniu nowego chelatu magnezu. Prace B+R pozwolą na uzyskanie etapu zaawansowania innowacyjnych rozwiązań pozwalającego na ich urynkowienie - obejmują bowiem ich testy i walidację w ramach pierwszej produkcji. Wskaźniki produktu: Liczba przedsiębiorstw otrzymujących wsparcie (C001): 1 Liczba przedsiębiorstw otrzymujących dotacje (CO02): 1 Inwestycje prywatne uzupełniające wsparcie publiczne dla przedsiębiorstw (dotacje) (CO06): 357257,70 PLN Liczba przedsiębiorstw wspartych w zakresie prowadzenia prac B+R: 1 Liczba realizowanych prac B+R: 1 Liczba realizowanych projektów B+R: 1 Wskaźnik rezultatu bezpośredniego: Liczba skomercjalizowanych wyników prac B+R prowadzonych przez przedsiębiorstwo w ramach projektu: 1 Suplement diety opracowany w ramach projektu zostanie skierowany na rynki: polski i zagraniczny, zarówno detaliczny (sprzedaż pod własną mark (Polish)
0 references
The project involves the R & D work leading to the development of magnesium chelate of technologies. A new active substance — chelated magnesium is used in a supplement to the next generation of diets. This supplement will permit the supply of magnesium in the form of a chelating agent in the form of chelate of magnesium ion time parameters and bioavailability, and consequently an optimised impact on maintaining the appropriate level of magnesium in the body. (a) industrial research on: The choice of a central metal precursor, the selection of the chemist, the choice of the synthetic pathway, — verification of the synthetic path on a laboratory scale, (b) experimental development of: — verification of a synthetic pathway of the technical and semi-technical scale, — the development of the final form of the technology together with the tests in real conditions. The project will allow the development of an innovative product in the world, a supplement to the new generation of diets based on the use of new magnesium chelate of products. R & D will allow the development of innovative solutions to enable them to be placed into market, as they include tests and validation in the context of the first production. Product indicators: Number of enterprises supported (C001): 1 Number of enterprises receiving subsidies (CO02): 1 Private investment complementary to public support for enterprises (grants) (CO06): PLN 357257,70 Number of enterprises supported for R & D activities: 1 Number of R & D ongoing: 1 Number of R & D projects carried out: 1 Direct result indicator: Number of R & D results generated by the company in the project: 1 A food supplement developed within the framework of the project will be directed to the markets of: Poland and foreign, both retail (sales under their own mark (English)
0 references
Identifiers
RPLD.01.02.02-10-0005/18
0 references